These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11748323)

  • 1. Less driving impairment on buprenorphine than methadone in drug-dependent patients?
    Soyka M; Horak M; Dittert S; Kagerer S
    J Neuropsychiatry Clin Neurosci; 2001; 13(4):527-8. PubMed ID: 11748323
    [No Abstract]   [Full Text] [Related]  

  • 2. Less impairment on one portion of a driving-relevant psychomotor battery in buprenorphine-maintained than in methadone-maintained patients: results of a randomized clinical trial.
    Soyka M; Hock B; Kagerer S; Lehnert R; Limmer C; Kuefner H
    J Clin Psychopharmacol; 2005 Oct; 25(5):490-3. PubMed ID: 16160628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of peak and trough levels of opioid maintenance therapy on driving aptitude.
    Baewert A; Gombas W; Schindler SD; Peternell-Moelzer A; Eder H; Jagsch R; Fischer G
    Eur Addict Res; 2007; 13(3):127-35. PubMed ID: 17570908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical trial on the acute effects of methadone and buprenorphine on actual driving and cognitive function of healthy volunteers.
    Strand MC; Vindenes V; Gjerde H; Mørland JG; Ramaekers JG
    Br J Clin Pharmacol; 2019 Feb; 85(2):442-453. PubMed ID: 30515857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of long-term maintenance treatment with buprenorphine on complex psychomotor and cognitive function.
    Shmygalev S; Damm M; Weckbecker K; Berghaus G; Petzke F; Sabatowski R
    Drug Alcohol Depend; 2011 Sep; 117(2-3):190-7. PubMed ID: 21353749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Driving capacity of patients treated with methadone and slow-release oral morphine.
    Giacomuzzi SM; Ertl M; Vigl A; Riemer Y; Günther V; Kopp M; Pilsz W; Haaser W
    Addiction; 2005 Jul; 100(7):1027. PubMed ID: 15955021
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuropsychological functioning of opiate-dependent patients: a nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment.
    Loeber S; Kniest A; Diehl A; Mann K; Croissant B
    Am J Drug Alcohol Abuse; 2008; 34(5):584-93. PubMed ID: 18720267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Driving impairment on buprenorphine and slow-release oral morphine in drug-dependent patients.
    Giacomuzzi S; Haaser W; Pilsz L; Riemer Y
    Forensic Sci Int; 2005 Sep; 152(2-3):323-4. PubMed ID: 15921868
    [No Abstract]   [Full Text] [Related]  

  • 9. [Interactions with methadone and buprenorphine].
    Bakke E; Bachs L
    Tidsskr Nor Laegeforen; 2009 Nov; 129(22):2364-6. PubMed ID: 19935937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls.
    Rapeli P; Fabritius C; Alho H; Salaspuro M; Wahlbeck K; Kalska H
    BMC Clin Pharmacol; 2007 Jun; 7():5. PubMed ID: 17565668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of cognitive function in patients under maintenance treatment with heroin, methadone, or buprenorphine and healthy controls: an open pilot study.
    Soyka M; Limmer C; Lehnert R; Koller G; Martin G; Küfner H; Kagerer S; Haberthür A
    Am J Drug Alcohol Abuse; 2011 Nov; 37(6):497-508. PubMed ID: 21851203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methadone and buprenorphine toxicity in children.
    Boyer EW; McCance-Katz EF; Marcus S
    Am J Addict; 2010; 19(1):89-95. PubMed ID: 20132125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of Single Doses of Methadone and Buprenorphine in Blood and Oral Fluid in Healthy Volunteers and Correlation With Effects on Psychomotor and Cognitive Functions.
    Strand MC; Ramaekers JG; Gjerde H; Mørland J; Vindenes V
    J Clin Psychopharmacol; 2019; 39(5):489-493. PubMed ID: 31305338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can patients receiving opioid maintenance therapy safely drive? A systematic review of epidemiological and experimental studies on driving ability with a focus on concomitant methadone or buprenorphine administration.
    Strand MC; Fjeld B; Arnestad M; Mørland J
    Traffic Inj Prev; 2013; 14(1):26-38. PubMed ID: 23259516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions on mixing diazepam with methadone or buprenorphine in maintenance patients.
    Lintzeris N; Mitchell TB; Bond A; Nestor L; Strang J
    J Clin Psychopharmacol; 2006 Jun; 26(3):274-83. PubMed ID: 16702892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid-related mortality and filled prescriptions for buprenorphine and methadone.
    Wikner BN; Öhman I; Seldén T; Druid H; Brandt L; Kieler H
    Drug Alcohol Rev; 2014 Sep; 33(5):491-8. PubMed ID: 24735085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing cognitive and psychomotor performance under long-term treatment with transdermal buprenorphine in chronic noncancer pain patients.
    Dagtekin O; Gerbershagen HJ; Wagner W; Petzke F; Radbruch L; Sabatowski R
    Anesth Analg; 2007 Nov; 105(5):1442-8, table of contents. PubMed ID: 17959980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Buprenorphine or methadone for detoxification of young opioid addicts?].
    Ebner R; Schreiber W; Zierer C
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S108-10. PubMed ID: 15570521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indicators of buprenorphine and methadone use and abuse: what do we know?
    Maxwell JC; McCance-Katz EF
    Am J Addict; 2010; 19(1):73-88. PubMed ID: 20132124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study.
    Anchersen K; Clausen T; Gossop M; Hansteen V; Waal H
    Addiction; 2009 Jun; 104(6):993-9. PubMed ID: 19392907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.